Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Based on the latest financial reports, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.11 Million ≈ $12.89 Million USD) by net assets (CN¥2.73 Billion ≈ $399.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Wolwo Bio-Pharmaceutical Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhejiang Wolwo Bio-Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SJW Group Common Stock NYSE:SJW	0.031x
Ningbo Yunsheng Co Ltd SHG:600366	-0.014x
Sonos Inc NASDAQ:SONO	-0.170x
Bros Eastern Co Ltd SHG:601339	0.071x
Karooooo Ltd NASDAQ:KARO	0.150x
ANI Pharmaceuticals Inc NASDAQ:ANIP	0.056x
Suzhou Jinhong Gas Co Ltd SHG:688106	0.033x
Terravest Capital Inc TO:TVK	0.038x

Annual Cash Flow Conversion Efficiency for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 300357 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.46 Billion ≈ $359.80 Million	CN¥262.44 Million ≈ $38.40 Million	0.107x	-36.68%
2023-12-31	CN¥2.30 Billion ≈ $337.10 Million	CN¥388.32 Million ≈ $56.82 Million	0.169x	-5.16%
2022-12-31	CN¥2.03 Billion ≈ $296.63 Million	CN¥360.28 Million ≈ $52.72 Million	0.178x	-11.44%
2021-12-31	CN¥1.80 Billion ≈ $262.90 Million	CN¥360.58 Million ≈ $52.76 Million	0.201x	+19.70%
2020-12-31	CN¥1.53 Billion ≈ $223.62 Million	CN¥256.22 Million ≈ $37.49 Million	0.168x	-2.68%
2019-12-31	CN¥1.35 Billion ≈ $197.83 Million	CN¥232.93 Million ≈ $34.08 Million	0.172x	-16.93%
2018-12-31	CN¥995.42 Million ≈ $145.66 Million	CN¥206.45 Million ≈ $30.21 Million	0.207x	+4.43%
2017-12-31	CN¥801.26 Million ≈ $117.25 Million	CN¥159.13 Million ≈ $23.29 Million	0.199x	+6.05%
2016-12-31	CN¥655.58 Million ≈ $95.93 Million	CN¥122.77 Million ≈ $17.97 Million	0.187x	-4.93%
2015-12-31	CN¥582.91 Million ≈ $85.30 Million	CN¥114.82 Million ≈ $16.80 Million	0.197x	+20.85%
2014-12-31	CN¥513.55 Million ≈ $75.15 Million	CN¥83.70 Million ≈ $12.25 Million	0.163x	-29.58%
2013-12-31	CN¥251.92 Million ≈ $36.86 Million	CN¥58.30 Million ≈ $8.53 Million	0.231x	+1.97%
2012-12-31	CN¥181.38 Million ≈ $26.54 Million	CN¥41.17 Million ≈ $6.02 Million	0.227x	+51.24%
2011-12-31	CN¥127.61 Million ≈ $18.67 Million	CN¥19.15 Million ≈ $2.80 Million	0.150x	-6.64%
2010-12-31	CN¥90.44 Million ≈ $13.23 Million	CN¥14.54 Million ≈ $2.13 Million	0.161x	+42.42%
2009-12-31	CN¥111.89 Million ≈ $16.37 Million	CN¥12.63 Million ≈ $1.85 Million	0.113x	--

About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

SHE:300357 China Drug Manufacturers - General

Market Cap

$1.80 Billion

CN¥12.27 Billion CNY

Market Cap Rank

#6469 Global

#1288 in China

Share Price

CN¥23.44

Change (1 day)

-0.93%

52-Week Range

CN¥20.83 - CN¥35.30

All Time High

CN¥5101.55